Trial
NCT04707157
Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Diabetic Peripheral Neuropathic Pain
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Diabetic Peripheral Neuropathic Pain
Intervention
LY3556050
Why stopped
The trial was slow to enroll, and the sponsor made a business decision to terminate the trial earlier than planned.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-02